Smoking and COVID-19: An Analysis of Demographics, Risk Factors, and Outcomes

Files

Authors

Andrew Vrtar, Oakland University William Beaumont School of Medicine Medical Student
Luca Cucullo
Richard H. Kennedy, Corewell Health East

Description

• Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a respiratory pathogen that first emerged in late 20191 and was declared as a pandemic by the World Health Organization (WHO) on March 11, 2020.
• Cigarette use is a significant public health concern throughout the world. Despite reductions in prevalence in recent years, tobacco smoking remains one of the main preventable causes of ill-health and premature death.
• Both tobacco smoking and vaping are phenomena that may increase the vulnerability of these individuals to COVID19 infection.4 Therefore, it is crucial to explore the medical consequences of and the effects of tobacco exposure in relation to COVID-19.

Publication Date

5-2024

Keywords

COVID-19, World Health Organization, tobacco smoking

Disciplines

Translational Medical Research

Recommended Citation

Vrtar A, Cucullo L, Kennedy RH. Smoking and COVID-19: An analysis of demographics, risk factors, and outcomes. Poster presented at: Oakland University William Beaumont School of Medicine Embark Capstone Colloquium; 2024 May; Rochester Hills, MI.

Comments

The Embark Capstone Colloquium at the Oakland University William Beaumont School of Medicine, Rochester Hills, MI, May, 2024.